2000
DOI: 10.1007/pl00002078
|View full text |Cite
|
Sign up to set email alerts
|

Toxischer Leberschaden durch HMG-CoA-Reduktase-Hemmer

Abstract: Therefore, when prescribing a HMG-CoA-reductase inhibitor, the possibility of liver damage should be mentioned and regular checks of the transaminase values should be performed.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2001
2001
2015
2015

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 11 publications
(1 citation statement)
references
References 8 publications
0
1
0
Order By: Relevance
“…In a small percentage of patients taking statin medications, liver enzymes and creatine phosphokinase (CPK) levels have risen [38]. A few patients have developed myalgia, some a severe rhabdomyolosis and even death.…”
Section: Smentioning
confidence: 99%
“…In a small percentage of patients taking statin medications, liver enzymes and creatine phosphokinase (CPK) levels have risen [38]. A few patients have developed myalgia, some a severe rhabdomyolosis and even death.…”
Section: Smentioning
confidence: 99%